Tech IPOs Take a Backseat as Biotech and Healthcare Dominate US Public Listings Jim Cramer Discusses Analog Devices ADI Market Position Amid Semiconductor Cycle Frances 1 Student Meal Program A Fiscal Policy to Support Higher Education Affordability Nike Stock Rebound May Face Headwinds Analysts Cautious AeroVironment Enhances AV Halo Platform With Two New Software Additions RBIs Rate Cut May Signal Shift in Monetary Policy Framework Nomura Suggests EML Q1 2026 Earnings EPS Falls Short of Estimates by 782 Galiano Gold Inc GAU Q1 2026 Earnings EPS Misses Estimates but Stock Rises 273 RenovoRx Inc RNXT Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Holds Steady Ormat Technologies ORA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Lithium Americas Corp LAC Q1 2026 Earnings NarrowerthanExpected Loss as Company Advances Thacker Pass OPLN Q1 2026 Earnings EPS Surpasses Estimates with 1243 Beat Willdan Group WLDN Holds Near Support as Technical Signals Suggest Consolidation Phase HUTCHMED HCM Holds Steady Near Support as Biotech Sector Faces Mixed Sentiment VAALCO Energy EGY Slips 15 as Energy Sector Faces Headwinds Key Support Levels in Focus Methanex MEOH Edges Higher Testing Key Resistance Levels Amid Modest Gains Gaxosai Inc GXAI Slides 345 as Selling Pressure Tests Key Support Levels PLUS THERAPEUTICS PSTV Holds Near Support as Modest Gains Persist BingEx FLX Rallies from Support Testing Key Resistance at 237 Fabrinet FN Slips 383 Key Support Levels in Focus After Pullback Silo Pharma SILO Surges 5 as SmallCap Biotech Recovers From Recent Lows Amprius Technologies AMPX Rallies 477 as Battery Sector Gains Momentum Atlas Lithium ATLX Extends Decline as Bearish Pressure Intensifies IRS Settlement Blocks Tax Audits Targeting Trump Family and Businesses CRGY Q1 2026 Earnings Strong EPS Beat Amid Energy Market Volatility Catalyst Bancorp Inc CLST Edges Higher as Stock Holds Above Key Support iRhythm Q1 2026 Earnings Significant EPS Beat Amid Revenue Uncertainty Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines CLRB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue AVTX Q1 2026 Earnings Narrowed Loss Beats Street Estimates as Pipeline Advances COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains PPHC Q4 2025 Earnings EPS Surges Past Estimates by Over 20 Yet Stock Slips AWK Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher on Regulatory Strength